OpenLegislation

Article 20 Obligation of the competent authority to grant, suspend and withdraw disease-free status

United Kingdom

Original text. Later amendments are not shown.

1.

The competent authority shall grant disease-free status at establishment level according to the compliance of the establishments’ operators with the requirements laid down in Article 18.

2.

The competent authority shall suspend or withdraw disease-free status at establishment level when the conditions for suspension or withdrawal have been met. Those conditions are laid down in:

(a)

Sections 3 and 4 of Chapters 1 and 2 of Part I of Annex IV for infection with Brucella abortus, B. melitensis and B. suis;

(b)

Sections 3 and 4 of Chapter 1 of Part II of Annex IV for infection with MTBC;

(c)

Sections 3 and 4 of Chapter 1 of Part III of Annex IV for EBL;

(d)

Sections 3 and 4 of Chapter 1 of Part IV of Annex IV for IBR/IPV;

(e)

Sections 3 and 4 of Chapter 1 of Part V of Annex IV for infection with ADV;

(f)

Sections 3 and 4 of Chapter 1 of Part VI of Annex IV for BVD.

3.

The competent authority shall specify:

(a)

the details of the testing regime, including as necessary, the disease specific requirements referred to in point (b) of Article 18(1) when the disease-free status is suspended or withdrawn; and

(b)

the maximum period of time during which disease-free status may be suspended where there is a breach of the conditions referred to in paragraph 2.

4.

The competent authority may attribute distinct health status to different epidemiological units of the same establishment provided that its operator:

(a)

has submitted for the consideration of the competent authority the information about the different epidemiological units established within the establishment to be granted distinct health status prior to any suspicion or confirmation of the disease in accordance with Articles 21 and 24;

(b)

has set up a system, to which the competent authority has access upon request, to trace the movements of animals and germinal products to, from and between the epidemiological units; and

(c)

has separated the epidemiological units by physical and management means and complies with any risk mitigating measures requested by the competent authority for that purpose.